Seeking Alpha

Geron (GERN) releases positive data from a clinical trial of its human embryonic stem cell-based...

Geron (GERN) releases positive data from a clinical trial of its human embryonic stem cell-based therapy. JPMorgan initiates coverage with an Overweight rating. Shares +5.4% premarket.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)